tiprankstipranks
Trending News
More News >
Neuland Laboratories Ltd. (IN:NEULANDLAB)
:NEULANDLAB
India Market

Neuland Laboratories Ltd. (NEULANDLAB) Financial Statements

Compare
3 Followers

Neuland Laboratories Ltd. Financial Overview

Neuland Laboratories Ltd.'s market cap is currently ₹189.58B. The company's EPS TTM is ₹75.5; its P/E ratio is 78.94; and it has a dividend yield of 0.08%. Neuland Laboratories Ltd. is scheduled to report earnings on November 7, 2025, and the estimated EPS forecast is ₹85.10. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue₹ 14.77B₹ 15.59B₹ 11.61B₹ 9.23B₹ 9.24B
Gross Profit₹ 7.26B₹ 8.25B₹ 5.47B₹ 3.70B₹ 3.63B
Operating Income₹ 2.58B₹ 5.32B₹ 2.34B₹ 960.90M₹ 1.10B
EBITDA₹ 4.20B₹ 4.75B₹ 2.79B₹ 1.40B₹ 1.63B
Net Income₹ 2.60B₹ 3.00B₹ 1.64B₹ 638.22M₹ 806.31M
Balance Sheet
Cash & Short-Term Investments₹ 3.67B₹ 1.03B₹ 454.16M₹ 84.68M₹ 105.51M
Total Assets₹ 21.80B₹ 18.33B₹ 15.80B₹ 13.83B₹ 13.25B
Total Debt₹ 1.57B₹ 953.90M₹ 1.28B₹ 2.41B₹ 1.82B
Net Debt₹ 252.07M₹ 78.14M₹ 830.34M₹ 2.35B₹ 1.80B
Total Liabilities₹ 6.55B₹ 5.50B₹ 5.86B₹ 5.43B₹ 5.38B
Stockholders' Equity₹ 15.25B₹ 12.83B₹ 9.94B₹ 8.41B₹ 7.86B
Cash Flow
Free Cash Flow₹ 1.11B₹ 1.18B₹ 1.71B₹ -372.97M₹ 839.65M
Operating Cash Flow₹ 3.17B₹ 2.61B₹ 2.37B₹ 603.89M₹ 1.89B
Investing Cash Flow₹ -2.98B₹ -1.50B₹ -614.99M₹ -955.16M₹ -844.24M
Financing Cash Flow₹ 249.61M₹ -692.82M₹ -1.36B₹ 377.21M₹ -1.14B
Currency in INR

Neuland Laboratories Ltd. Earnings and Revenue History

Neuland Laboratories Ltd. Debt to Assets

Neuland Laboratories Ltd. Cash Flow

Neuland Laboratories Ltd. Forecast EPS vs Actual EPS